Piramal Pharma Ltd Nine Monthly Results

Gross Sales

6,397.11

5,618.8

4,917.97

4,427.74

Excise Duty

0

0

0

0

Net Sales

6,397.11

5,618.8

4,917.97

4,427.74

Other Operating Income

0

0

0

0

Other Income

149.49

196.46

247.16

237.63

Total Income

6,546.6

5,815.26

5,165.13

4,665.37

Total Expenditure

5,513.27

4,984.74

4,647.96

3,891.22

PBIDT

1,033.33

830.52

517.17

774.15

Interest

317.91

334.27

239.93

141.09

PBDT

715.42

496.25

277.24

633.06

Depreciation

573.58

544.44

492.28

421.02

Minority Interest Before NP

0

0

0

0

Tax

216.31

84.42

77.73

113.35

Deferred Tax

-12.1

-49.16

-56.2

-73.21

Reported Profit After Tax

-62.37

-83.45

-236.57

171.9

Minority Interest After NP

0

0

0

0

Net Profit after Minority Interest

-62.37

-83.45

-236.57

171.9

Extra-ordinary Items

0

24.26

-4.44

-15.08

Adjusted Profit After Extra-ordinary item

-62.37

-107.71

-232.13

186.98

EPS (Unit Curr.)

-0.47

-0.66

-1.99

1.45

Book Value (Unit Curr.)

0

0

0

0

Dividend (%)

0

0

0

0

Equity

1,323.58

1,322.95

1,193.32

1,185.91

Public Shareholding (Number)

0

0

0

0

Public Shareholding (%)

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

PBIDTM(%)

16.15

14.78

10.51

17.48

PBDTM(%)

11.18

8.83

5.63

14.29

PATM(%)

-0.97

-1.48

-4.81

3.88